Research

Hormonal

Glucagon receptor blockade or suppression prevents the catabolic consequences of insulin deficiency (hyperglycemia, ketoacidosis) in animal models.

In animal models, preventing glucagon from acting stops diabetes even without insulin. This suggests that therapies blocking glucagon could potentially manage blood sugar without the need for high-dose insulin, reducing side effects.

StrongSupportsVERY_HIGH confidence
In these Gcgr–/– mice... total β cell destruction did not result in any of the diabetic abnormalities thought to be caused by insulin deficiency.
Roger H. Unger et al. · Journal of Clinical Investigation · 2012

Why this rating

Definitive proof from knockout mice where beta cells were destroyed but mice remained normoglycemic.

Source

Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover

Roger H. Unger et al. · Journal of Clinical Investigation · 2012

DOI 10.1172/jci60016

narrative_reviewCited 667×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →